Biofrontera (BFRI) Financial Statements & Analysis

Biofrontera (BFRI) Income Statement

Biofrontera reported revenue of $41.70M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 11.7% from $37.32M a year earlier. Biofrontera posted a net loss of $10.54M, compared with a net loss of $17.76M a year earlier. Gross margin was 78.7% and operating margin -21.9%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $12.00M, up 32.9% from the same quarter a year earlier.

Biofrontera Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Biofrontera Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Mar 2022	Dec 2021	Dec 2020	Dec 2019
Revenue & Gross Profit
Revenue	41.71	37.32	34.07	28.67	24.10	24.10	18.85	26.18
Cost of Revenue	8.90	18.61	17.44	15.19	12.74	12.74	9.07	12.41
Gross Profit	32.80	18.71	16.63	13.49	11.36	11.36	9.78	13.77
Operating Expenses
Research & Development	3.72	2.09	0.08	0.00	0.00	-	0.00	0.00
Selling, General & Administrative	38.13	33.84	39.13	35.87	37.21	37.21	18.12	28.70
Operating Expenses	41.95	35.92	39.30	35.87	36.56	37.21	18.12	28.70
Operating Income	-9.15	-17.21	-22.68	-22.38	-25.20	-25.85	-8.33	-14.92
Other Income/Expense
Interest Income	0.00	0.07	0.13	0.18	0.02	0.02	0.03	0.03
Interest Expense	0.45	-2.11	0.60	0.37	0.36	0.36	-2.90	2.16
Other Income/Expense	-1.36	-0.53	2.56	21.98	-12.46	-11.46	0.08	3.97
Income
Income Before Tax	-10.51	-17.74	-20.12	-0.61	-37.66	-37.66	-10.92	-10.95
Income Tax Expense	0.03	0.02	0.01	0.03	0.06	0.06	0.06	0.03
Net Income	-10.54	-17.76	-20.13	-0.64	-37.71	-37.71	-10.99	-10.98
Net Income - Continuous Operations	-10.54	-17.76	-20.13	-0.64	-37.71	-37.71	-10.99	-10.98
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-
EBITDA	-9.19	-16.79	-18.45	0.93	-36.76	-36.76	-7.77	-8.15
EBIT	-11.35	-17.21	-21.35	-0.24	-	-37.30	-8.33	-
Depreciation & Amortization	0.87	0.42	1.06	1.17	0.54	0.54	0.56	0.67
Earnings Per Share
Basic EPS	-1.00	-3.00	-13.00	-	-44.00	-86.00	-19.00	-18.00
Diluted EPS	-1.00	-3.00	-13.00	-	-44.00	-86.00	-19.00	-18.00
Basic Shares Outstanding	10.17	5.52	1.55	1.33	0.86	0.44	0.58	0.61
Diluted Shares Outstanding	11.65	5.52	1.55	1.33	0.86	0.44	0.58	0.61

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Biofrontera Financial Statements

What was Biofrontera's revenue in fiscal 2025?

Biofrontera reported revenue of $41.70M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 11.7% from $37.32M a year earlier.

Is Biofrontera profitable?

No. Biofrontera reported a net loss of $10.54M in fiscal 2025. In fiscal 2024 it lost $17.76M.

What is Biofrontera's operating margin?

Biofrontera's operating income was −$9.15M on revenue of $41.70M in fiscal 2025, an operating margin of -21.9%, compared with -46.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition